crossspeci
transmiss
virus
well
document
understand
virus
infect
spread
new
host
central
understand
pathogenesi
infect
emerg
diseas
mous
mammari
tumour
viru
mmtv
prototyp
type
b
betaretroviru
infect
murida
rodent
mu
genu
specif
associ
mammari
adenocarcinoma
tcell
lymphoma
mous
transferrin
receptor
use
mmtv
initi
infect
murin
cell
human
ortholog
even
though
report
bind
mmtv
effici
serv
entri
receptor
mmtv
viru
entri
block
postattach
phase
due
lack
intern
mmtvbound
subsequ
traffick
late
endosom
fusion
membran
occur
interestingli
although
viru
use
cell
entri
sever
mmtv
strain
shown
product
infect
addit
murin
cell
variou
heterolog
cell
line
includ
human
origin
albeit
less
effici
murin
cell
also
report
mmtv
sequenc
detect
human
breast
cancer
primari
biliari
cirrhosi
specimen
well
canin
felin
neoplast
normal
mammari
tissu
recent
report
also
show
mmtvlike
virus
circul
wide
among
rodent
mammalian
speci
belief
come
identif
mmtvlike
endogen
retrovirus
erv
fossil
extinct
virus
integr
genom
host
speci
rodent
popul
devoid
infecti
mmtv
mammalian
host
wide
geograph
evolutionari
divers
addit
evid
support
notion
mmtv
may
abl
cross
speci
barrier
virus
circul
wide
among
rodent
base
evolutionari
analysi
rodent
amino
acid
residu
interact
mmtvlike
viru
envelop
residu
undergon
posit
select
mutat
compromis
interact
betaretroviru
entri
glycoprotein
time
entri
glycoprotein
receptor
bind
site
rb
residu
nterminusproxim
region
mmtv
surfac
subunit
su
domain
evolv
acquir
compat
particular
host
ortholog
molecular
arm
race
mmtv
env
rodent
drive
endless
round
posit
select
mutat
affect
interact
viru
host
well
mention
evid
support
concept
mmtvlike
virus
circul
wide
natur
particularli
adept
overcom
cellular
barrier
prevent
crossspeci
transmiss
consist
model
observ
continu
passag
mmtv
human
felin
cell
line
result
adapt
viru
infect
variou
nonmurin
cell
effici
parent
viru
present
natur
adapt
mutat
respons
phenotyp
chang
unknown
howev
envisag
chang
receptor
bind
site
may
allow
emerg
host
rang
variant
scenario
would
reminisc
report
virus
belong
two
viru
famili
parvovirida
canin
felin
parvovirus
arenavirida
sever
rodent
human
arenavirus
also
use
primari
cellular
receptor
trigger
cellular
entri
canin
parvoviru
type
hostrang
variant
close
relat
felin
parvoviru
gain
access
dog
acquisit
mutat
capsid
protein
allow
effici
bind
viru
express
surfac
canin
cell
appear
transmiss
cat
dog
indirect
event
involv
passag
anoth
carnivor
speci
racoon
contribut
adapt
capsid
protein
canin
emerg
canin
parvoviru
also
indirect
evid
suggest
new
world
arenavirus
abl
though
minor
chang
arenaviru
entri
glycoprotein
expand
host
rang
sever
virus
typic
circul
rodent
speci
found
america
emerg
human
popul
caus
hemorrhag
fever
lethal
diseas
zoonot
potenti
correl
abil
use
human
addit
nativ
rodent
wherea
clade
b
arenaviru
caus
human
diseas
eg
amapari
viru
tacarib
viru
util
cell
entri
pathogen
clade
b
arenavirus
effect
recognis
human
ortholog
lead
effici
infect
human
cell
turn
zoonot
transmiss
interestingli
shown
chang
littl
one
amino
acid
residu
suffici
nonpathogen
arenavirus
gain
use
receptor
cell
entri
similarli
mutat
amino
acid
residu
enabl
convers
mous
compat
cell
entri
receptor
pathogen
arenavirus
aforement
studi
infer
minor
chang
receptor
bind
domain
may
dramat
chang
arenaviru
tropism
use
wildtyp
recombin
egfpcontain
viru
carri
mmtv
env
recent
shown
mmtv
like
strain
abl
infect
human
cell
albeit
less
effici
mous
cell
establish
infect
howev
suffici
enabl
viru
spread
everi
cell
cultur
infect
wildtyp
mmtv
envcarri
mmtv
recombin
virion
block
heatinactiv
inhibitor
revers
transcript
azt
rule
nonspecif
mechan
viral
transfer
furthermor
infect
requir
intact
mmtv
envelop
protein
sinc
neutral
antimmtv
antibodi
block
infect
wildtyp
mmtv
envcarri
mmtv
recombin
virion
persist
infect
cell
produc
infecti
viru
particl
capabl
infect
naiv
human
breast
cell
cultur
infect
could
block
neutral
antimmtv
antibodi
heatinactiv
azt
demonstr
viru
particl
releas
persist
infect
cell
antigen
relat
viru
produc
murin
cell
show
presenc
provir
dna
infect
cell
due
authent
receptormedi
revers
transcriptasedepend
infect
process
herein
analys
whether
replic
mmtv
human
cell
result
sequenc
alter
facilit
spread
surviv
new
host
consist
previou
report
show
replic
mmtv
nonmurin
cell
lead
format
variant
replic
faster
human
cell
furthermor
demonstr
mutat
respons
least
part
phenotyp
chang
locat
receptor
bind
site
viral
glycoprotein
final
present
evid
show
human
requir
effici
infect
human
cell
replic
kinet
mutant
suggest
viru
adapt
use
anoth
cell
surfac
molecul
cell
entri
previous
shown
wildtyp
mmtv
recombin
egfp
contain
viru
carri
mmtv
env
could
infect
cultur
human
cell
via
specif
interact
viral
envelop
cell
surfac
receptor
addit
wildtyp
viru
mmtv
harvest
cell
cultur
fluid
mmtvinduc
mous
mammari
tumour
cell
line
abl
replic
human
mammari
epitheli
cell
line
ultim
lead
infect
everi
cell
cultur
persist
infect
human
cell
produc
infecti
viru
particl
design
mmtv
capabl
infect
naiv
human
breast
cell
cultur
infect
mmtv
block
neutral
antimmtv
antibodi
demonstr
viru
particl
releas
persist
infect
human
cell
antigen
relat
viru
produc
murin
cell
extend
earlier
work
address
question
whether
mmtv
abl
product
replic
human
breast
cell
whether
replic
kinet
viru
nonmurin
cell
chang
rel
parent
viru
set
experi
cell
free
viru
obtain
cell
cultur
fluid
human
cell
persist
infect
mmtv
week
post
infect
wildtyp
viru
obtain
cell
cultur
fluid
mmtv
induc
mous
mammari
tumour
cell
line
deriv
mous
strain
use
infect
naiv
uninfect
cell
prior
infect
viru
particl
titer
determin
realtim
taqman
rtpcr
target
end
env
normal
viru
level
use
infect
human
cell
quantif
provir
dna
one
week
post
infect
use
realtim
taqman
pcr
show
approxim
equival
provir
load
infect
cell
next
cell
cultur
presenc
absenc
dex
gdna
extract
regular
time
point
agreement
previous
publish
data
increas
level
provir
dna
detect
within
cell
infect
mmtv
time
figur
e
assess
semiquantit
target
mmtv
ltrgag
region
quantit
target
end
env
code
region
pcr
importantli
increas
provir
dna
level
also
detect
cell
infect
mmtv
figur
e
interestingli
infecti
particl
releas
persist
infect
human
cell
mmtv
show
increas
replic
kinet
human
cell
compar
virus
produc
cell
specif
cell
infect
mmtv
carri
copi
provir
dna
day
post
infect
figur
contrast
cell
infect
mmtv
need
cultur
least
day
cell
carri
copi
provir
dna
figur
increas
depend
presenc
dex
cultiv
medium
sinc
notic
augment
provir
dna
level
detect
cell
cultur
absenc
dex
figur
e
collect
find
show
mmtv
viru
produc
persist
infect
human
cell
abl
replic
naiv
human
cell
also
exhibit
faster
replic
kinet
human
cell
next
determin
twelv
complet
mmtv
provir
sequenc
minu
gag
gene
contain
sequenc
preclud
clone
growth
e
coli
compar
mmtv
sequenc
identifi
viru
prepar
murin
mammari
carcinoma
cell
recombin
event
sequenc
human
origin
identifi
provir
sequenc
deriv
virus
undergon
sever
replic
cycl
human
cell
similarli
evid
suggest
viru
capabl
replic
human
cell
variant
result
recombin
mous
genom
sequenc
includ
endogen
mtv
sever
nucleotid
substitut
detect
pro
portion
pol
env
sag
gene
data
shown
greatest
number
point
mutat
found
env
code
region
next
sought
analyz
whether
select
pressur
shape
genet
variat
cultiv
human
cell
calcul
ratio
number
nonsynonym
mutat
per
nonsynonym
site
dn
synonym
mutat
per
synonym
site
ds
use
infer
direct
magnitud
natur
select
act
protein
encod
sequenc
dnd
ratio
lower
one
impli
purifi
select
wherea
ratio
greater
one
impli
posit
fix
select
ratio
calcul
use
tamuranei
method
implement
mega
softwar
packag
estim
number
nonsynonym
synonym
chang
occur
codon
throughout
evolut
averag
dnd
ratio
entir
env
code
region
slightli
less
one
suggest
entir
env
neutral
select
howev
differ
region
singl
gene
expos
differ
select
pressur
analys
dnd
ratio
entir
length
gene
use
slide
window
codon
importantli
sever
region
env
found
posit
select
viru
cultiv
human
cell
figur
left
panel
includ
segment
env
gene
encod
signal
peptid
receptor
bind
domain
rbd
nterminu
su
domain
central
part
su
ntermin
part
tm
domain
figur
right
panel
identif
posit
select
pressur
rbd
may
particular
interest
nonsynonym
mutat
region
mediat
interact
viru
receptor
cell
surfac
may
alter
viru
tropism
facilit
infect
human
cell
interestingli
one
nt
substitut
lead
nonconserv
amino
acid
substitut
glutam
acid
place
glycin
posit
su
fiveaminoacid
stretch
polar
hydrophob
residu
believ
constitut
receptor
bind
site
rb
detect
twelv
mmtv
clone
mmtv
viru
figur
c
particular
polymorph
previous
report
su
sequenc
mmtv
riii
viru
adapt
human
breast
cancer
cell
line
design
riiim
addit
one
twelv
mmtv
clone
also
found
carri
addit
nonsynonym
mutat
arginin
lysin
substitut
posit
su
rb
su
figur
result
impli
rbd
virus
replic
human
cell
posit
select
pressur
chang
region
may
facilit
infect
human
cell
turn
lead
faster
replic
kinet
point
mutat
lead
amino
acid
substitut
found
outsid
region
encod
rbd
heparin
bind
domain
hbd
contrast
mutat
describ
none
polymorph
found
twelv
mmtv
clone
surprisingli
high
frequenc
nonsynonym
mutat
also
identifi
sag
code
region
figur
left
panel
region
also
appear
posit
select
pressur
reason
observ
phenomenon
clear
expect
conserv
gene
gene
encod
enzymat
compon
viru
pol
dnd
ratio
region
close
one
suggest
segment
viru
neutral
select
figur
left
panel
next
analys
whether
mmtv
sequenc
carri
signatur
human
express
cell
intrins
immun
factor
catalys
deamin
deoxycitidin
c
deoxyuridin
u
minu
strand
viral
dna
revers
transcript
subsequ
synthesi
plu
strand
deamin
minu
strand
templat
induc
g
mutat
newli
gener
plu
strand
viral
dna
hypothesis
variant
exhibit
faster
replic
kinet
result
mutagenesi
human
cell
select
preexist
quasispeci
contain
hallmark
mutagenesi
c
u
transit
ssdna
furthermor
analysi
sequenc
context
deamin
deoxycitidin
also
use
indirect
method
confirm
human
origin
infect
cell
due
fact
mous
deaminas
target
deoxycytosin
within
differ
dna
sequenc
context
commonli
target
last
c
run
c
ssdna
wherea
mous
prefer
ttc
target
observ
mutat
could
attribut
activ
figur
c
substitut
addit
commonli
target
cytosin
within
canon
sequenc
context
recogn
figur
importantli
activ
also
like
account
substitut
receptor
bind
sequenc
detect
twelv
mmtv
clone
glycin
codon
ggg
ccc
ssdna
mutat
gag
cuc
encod
glutam
acid
taken
togeth
data
provid
evid
support
concept
larg
proport
mutat
mmtv
provir
dna
attribut
mutagenesi
hallmark
cytosin
deamin
substanti
origin
hypothesi
mmtv
capabl
product
infect
human
cell
addit
mutagenesi
may
least
part
explain
rel
long
cultiv
time
requir
detect
infect
everi
human
cell
cultur
find
whether
mutat
facilit
infect
human
cell
mutat
introduc
mmtv
env
construct
wildtyp
mutant
env
subsequ
use
gener
egfpcarri
mmtv
recombin
virion
use
mmtvbase
vector
system
analog
third
gener
lentivir
vector
product
system
construct
vector
system
describ
elsewher
briefli
replic
incompet
vector
particl
gener
cotransfect
cell
mmtvbase
vector
construct
contain
egfp
gene
togeth
packag
construct
rev
express
construct
final
plasmid
express
wt
mutant
envelop
protein
control
use
mmtv
particl
pseudotyp
amphotrop
mlv
env
filter
supernat
transfect
cell
subsequ
use
transduc
human
mous
nmumg
mammari
epitheli
cell
first
demonstr
mutant
env
effici
process
total
cell
extract
wt
mutant
cell
subject
western
blot
analysi
determin
level
viral
protein
mutant
env
process
matur
su
tm
figur
indic
gross
chang
env
process
occur
result
sequenc
alter
virus
next
test
abil
transduc
nmumg
cell
equal
amount
viru
quantifi
western
blot
analysi
serial
dilut
concentr
virion
use
antimmtv
ca
antibodi
use
transduct
human
cell
mutant
exhibit
approxim
increas
transduct
effici
compar
wt
env
carri
viru
figur
mous
cell
howev
mutat
caus
modest
increas
transduct
level
figur
infect
mmtvbase
vector
carri
mutant
env
like
infect
vector
carri
wt
env
complet
block
preincub
neutral
goat
antimmtv
antibodi
figur
contrast
pretreat
virion
nonspecif
serum
effect
infect
figur
importantli
alter
infect
observ
mlv
envcarri
pseudovirion
preincub
antimmtv
antibodi
figur
rule
nonspecif
infect
inhibit
activ
serum
addit
infect
wt
mutant
envcarri
mmtv
virion
block
heatinactiv
minut
inhibitor
revers
transcript
azt
figur
rule
nonspecif
mechan
vector
transfershow
vector
transfer
due
authent
revers
transcriptasedepend
infect
process
collect
data
impli
mutat
least
part
respons
adapt
mmtv
new
host
addit
specif
neutral
vector
infect
demonstr
mutant
env
particl
like
wt
env
particl
reli
specif
interact
viral
envelop
cell
surfac
receptor
mediat
infect
human
cell
virus
differ
famili
includ
retrovirus
undergon
multipl
passag
cell
cultur
shown
exhibit
higher
affin
glycosaminoglycan
heparan
sulfat
hs
test
whether
mutat
confer
hsbind
phenotyp
wildtyp
mutant
recombin
viruscontain
supernat
incub
presenc
absenc
increas
amount
hs
use
transduc
cell
agreement
previous
publish
data
treatment
wildtyp
viru
solubl
hs
result
dosedepend
decreas
infecti
titer
demonstr
bind
hs
cell
surfac
play
role
mmtv
infect
figur
importantli
increas
amount
hs
caus
similar
decreas
wildtyp
mutant
infecti
titer
suggest
increas
infect
accompani
nonconserv
mutat
due
enhanc
interact
proteoglycan
figur
increas
infect
mutant
could
due
increas
env
bind
receptor
alter
affect
subsequ
step
infect
pathway
membran
fusion
attempt
differenti
two
possibl
virusbind
assay
perform
nmumg
cell
incub
equal
amount
wildtyp
mutant
virion
stain
antimmtv
antiserum
analys
flow
cytometri
fcm
detect
bound
viru
viru
carri
mutant
mmtv
env
bound
human
cell
effici
viru
carri
wt
env
figur
differ
bind
effici
observ
wt
mutant
env
nmumg
cell
figur
corrobor
result
analys
whether
viru
carri
mutant
envelop
due
tighter
bind
cell
surfac
less
effici
egress
produc
cell
vector
contain
either
wt
mutant
env
constitut
releas
transfect
cell
vector
trap
cell
surfac
releas
follow
subtilisin
treatment
quantifi
western
blot
analysi
antimmtvca
antibodi
major
wt
mmtv
env
virion
releas
supernat
figur
left
panel
wt
subtilisin
rel
low
amount
viru
trap
cell
surfac
produc
cell
figur
left
panel
wt
subtilisin
contrast
mutant
mmtv
env
higher
amount
viru
retain
cell
surfac
produc
cell
amount
found
wt
mmtv
env
figur
left
panel
subtilisin
also
reflect
lower
amount
constitut
releas
viru
detect
supernat
figur
left
panel
subtilisin
figur
inset
collect
data
suggest
nonconserv
mutat
enhanc
interact
viru
particl
receptor
cell
surfac
next
analys
whether
nonconserv
mutat
alter
charg
rb
allow
mmtv
use
cell
entri
scenario
would
reminisc
report
new
world
clade
b
arenavirus
sever
minor
chang
amino
acid
residu
rbd
acquir
compat
emerg
human
popul
zoonot
transmiss
chines
hamster
ovari
cho
cell
use
identif
mmtv
receptor
transfect
plasmid
express
human
mous
respect
cell
subsequ
transduc
egfp
express
mmtvbase
vector
carri
either
wt
mutant
env
control
mmtvbase
vector
pseudotyp
either
junin
junv
pathogen
clade
b
arenaviru
tacarib
tcrv
nonpathogen
clade
b
arenaviru
glycoprotein
gp
includ
gp
pathogen
new
world
clade
b
arenavirus
use
cellular
receptor
wherea
nonpathogen
strain
use
cell
entri
hand
play
role
clade
b
arenaviru
cell
entri
expect
express
cho
cell
result
signific
increas
transduct
level
mmtvbase
vector
pseudotyp
junv
gp
figur
affect
transduct
rate
vector
pseudotyp
tcrv
gp
figur
addit
effect
transduct
effici
either
junv
tcrv
gp
pseudotyp
vector
figur
contrast
arenavirus
express
caus
signific
increas
transduct
level
mmtvbase
vector
carri
wt
env
respect
fold
figur
importantli
express
effect
transduct
effici
figur
similar
result
also
obtain
wildtyp
mmtv
viru
harvest
cell
cultur
fluid
mmtvinduc
mous
mammari
tumour
cell
line
use
addit
file
figur
also
case
presenc
allow
effici
entri
viru
cho
cell
next
analys
whether
downmodul
express
effect
transduct
effici
cell
treat
mrnatarget
sirna
prior
incub
mmtv
vector
carri
variou
env
control
cell
transfect
nontarget
sirna
use
similar
previou
report
deplet
cell
result
approxim
reduct
transduct
level
junv
gp
pseudotyp
vector
wherea
level
tcrv
gp
pseudotyp
vector
remain
unaffect
figur
importantli
transduct
effici
mmtv
envcarri
vector
condit
reduc
endogen
express
remain
compar
obtain
cell
express
similar
result
observ
wt
mutant
env
figur
infect
wildtyp
mmtv
viru
harvest
cell
also
unaffect
knockdown
addit
file
figur
taken
togeth
result
show
serv
receptor
mediat
entri
wildtyp
viru
vector
contain
wildtyp
well
env
furthermor
present
evid
suggest
mmtv
variant
carri
mutat
although
exhibit
greater
infect
human
cell
use
mediat
entri
human
cell
knockdown
result
complet
elimin
protein
express
therefor
may
possibl
residu
level
may
affect
mmtv
entri
process
exampl
remain
may
suffici
initi
low
level
viru
entri
altern
mmtv
bind
presenc
protein
cell
surfac
may
trap
viru
andor
hinder
interact
molecul
cell
surfac
provid
definit
answer
whether
role
play
mmtv
infect
knock
cell
use
crispr
cluster
regularli
interspac
short
palindrom
repeat
type
ii
specif
use
lenticrispr
vector
product
system
enabl
simultan
deliveri
mammalian
codonoptimis
nucleas
singl
guid
rna
sgrna
puromycin
select
marker
target
cell
test
efficaci
gene
knockout
lenticrispr
transduct
sgrna
target
egfp
clone
lenticrispr
plasmid
lenticrispr
plasmid
transfect
cell
togeth
packag
vector
hiv
rev
express
construct
vector
encod
vesicular
stomat
viru
vsvg
env
gener
replicationdefect
lentivir
vector
transduct
filter
supernat
transfect
cell
subsequ
use
transduc
cell
express
egfp
follow
day
select
puromycin
lenticrispr
abolish
egfp
fluoresc
major
cell
determin
flow
cytometri
analysi
data
shown
target
knockout
sgrna
target
sequenc
within
exon
clone
lenticrispr
plasmid
use
transduct
cell
figur
b
transduc
cell
cultur
presenc
puromycin
total
day
individu
clone
isol
expand
total
clone
use
analysi
first
assay
genom
mutat
statu
locu
individu
clone
system
induc
doublestrand
dna
break
repair
mainli
errorpron
nonhomolog
end
join
nhej
thirti
three
percent
clone
bore
mutat
locu
determin
endonucleas
assay
dna
sequenc
figur
clone
one
contain
mutat
three
copi
locu
cell
carri
two
copi
chromosom
well
deriv
chromosom
der
gene
locat
determin
dna
sequenc
figur
mutat
led
prematur
stop
codon
effect
disrupt
open
read
frame
orf
yield
truncat
protein
product
addit
file
figur
success
knockout
confirm
western
blot
cell
lysat
figur
next
cell
transduc
panel
mmtvbase
vector
carri
wt
mmtv
env
mutant
env
junv
gp
tcrv
gp
control
one
clone
carri
mutat
show
similar
level
express
parent
cell
use
expect
transduct
effici
junv
gppseudotyp
vector
compromis
cell
compar
cell
express
figur
tcrv
gp
vector
transduct
rate
unaffect
express
figur
contrast
mmtvbase
vector
carri
either
wt
mutant
mmtv
env
transduc
cell
similar
effici
cell
express
figur
abil
mmtvbase
vector
carri
either
wt
mutant
mmtv
env
transduc
cell
complet
block
preincub
neutral
goat
antimmtv
antibodi
figur
contrast
pretreat
virion
nonspecif
serum
effect
abil
vector
infect
cell
figur
importantli
tcrv
gp
pseudotyp
vector
preincub
antimmtv
antibodi
still
abl
transduc
cell
figur
rule
nonspecif
infect
inhibit
activ
serum
result
suggest
mmtvmediat
infect
cell
reli
specif
interact
viral
envelop
cell
surfac
receptor
furthermor
incub
supernat
minut
prior
transduct
knockout
cell
abrog
infect
vector
regardless
env
use
figur
show
transmiss
vector
dna
temperatur
sensit
expect
vector
transduct
rather
mean
dna
transfer
final
addit
azt
cultur
medium
transduc
cell
inhibit
transduct
figur
demonstr
presenc
vector
dna
transduc
cell
result
revers
transcriptiondepend
process
expect
vector
transduct
collect
knockout
experi
support
concept
mmtv
capabl
infect
cell
absenc
identifi
mutat
receptor
bind
site
mmtv
env
emerg
result
posit
select
cell
lack
primari
receptor
amplifi
phenotyp
therefor
propos
molecul
cell
surfac
capabl
mediat
entri
mmtv
cell
thu
serv
altern
receptorcoreceptor
data
present
demonstr
mmtv
releas
persist
infect
human
cell
mmtv
exhibit
markedli
faster
replic
kinet
human
cell
parent
viru
specif
mmtv
requir
fourtim
less
time
day
infect
everi
cell
cell
cultur
eventhough
infecti
dose
equival
use
virus
produc
murin
cell
use
sever
mechan
may
explain
observ
variat
replic
kinet
differ
viru
prepar
percentag
defect
virion
ii
pseudotyp
human
genomeencod
envelop
protein
iii
recombin
human
cellular
dna
human
endogen
provir
sequenc
iv
select
preexist
quasispeci
wildtyp
mmtv
popul
v
random
mutat
event
follow
select
variant
exhibit
faster
replic
kinet
human
cell
believ
first
two
mechan
readili
rule
convict
base
observ
mmtv
virion
contain
surfac
antigen
determin
ident
similar
found
mmtv
releas
murin
cell
judg
complet
neutral
mmtv
infect
mmtvspecif
antibodi
similarli
real
time
rtpcr
result
combin
singl
round
infect
experi
reveal
significantli
greater
level
defect
virus
viru
prepar
gener
murin
human
cell
respect
furthermor
mmtv
contain
sequenc
virus
human
genom
determin
sequenc
analysi
instead
mmtv
sequenc
complet
genom
except
gagcod
region
contain
sequenc
preclud
clone
growth
e
coli
origin
mmtv
thu
recombin
sequenc
human
origin
also
account
observ
variat
speed
viru
replic
final
upon
analysi
mmtv
found
carri
specif
signatur
cytosin
deamin
hallmark
cytosin
deamin
substanti
origin
hypothesi
mmtv
capabl
product
infect
human
cell
addit
mutagenesi
may
least
part
also
explain
rel
long
cultiv
time
requir
detect
infect
everi
human
cell
cultur
next
analys
whether
select
pressur
shape
genet
variat
replic
human
cell
found
region
within
mmtv
genom
includ
segment
env
gene
encod
rbd
nterminu
su
domain
central
part
su
ntermin
part
tm
domain
strong
posit
fixat
select
pressur
point
mutat
identifi
su
subunitencod
portion
env
uniqu
mmtv
sequenc
found
strain
mmtv
addit
bulk
polymorph
uniqu
individu
provir
plasmid
clone
sever
nonsynonym
mutat
found
rbd
mutat
situat
directli
fiveaminoacid
stretch
polar
hydrophob
residu
believ
constitut
rb
mutat
rb
may
thu
alter
mmtv
su
tropism
allow
mmtv
adapt
new
host
rang
note
mmtv
virus
contrast
parent
viru
mmtv
carri
glutam
acid
substitut
glycin
posit
su
figur
residu
shown
map
outer
surfac
su
domain
occupi
posit
within
concav
surfac
consist
role
receptor
bindinginteract
nonconserv
alter
small
noncharg
amino
acid
neg
charg
polar
residu
expect
impos
electrostat
steric
effect
rb
figur
mutat
may
thu
alter
viru
receptor
use
give
rise
adapt
viru
capabl
infect
heterolog
cell
increas
effici
hiv
mutat
alter
charg
around
predict
site
give
rise
variant
enter
cell
manner
enabl
viru
expand
target
cell
rang
addit
charg
long
recogn
differ
loop
sequenc
mutat
alter
loop
charg
shown
play
import
role
determin
viru
tropism
ie
coreceptor
use
mediat
cell
entri
introduct
charg
glutam
acid
place
glycin
wt
mmtv
env
greatli
increas
effici
mmtv
recombin
virion
transduc
human
cell
contrast
substitut
caus
modest
alter
transduct
level
mous
cell
furthermor
mmtv
recombin
virion
carri
glutam
acid
posit
bound
human
cell
effici
virion
carri
wt
env
differ
bind
howev
observ
wildtyp
mutant
virion
mous
cell
data
impli
mmtv
produc
murin
cell
abl
adapt
new
host
rang
least
part
shape
receptor
bind
domain
optim
interact
receptor
studi
carri
mmtv
envpseudotyp
mlv
virus
show
use
mmtv
initi
infect
mous
cell
human
ortholog
howev
report
molecul
incap
mediat
mlvmmtv
entri
even
though
bound
pseudoviru
effici
therefor
initi
hypothes
mmtv
replic
human
cell
adapt
mutat
rb
enabl
util
cell
entri
scenario
would
reminisc
report
anoth
group
virus
use
primari
cellular
receptor
new
world
clade
b
arenavirus
virus
endem
rodent
popul
found
america
viru
evolv
compat
specif
ortholog
encod
respect
host
speci
sever
virus
howev
chang
amino
acid
residu
rbd
acquir
compat
allow
effici
infect
human
cell
enabl
zoonot
transmiss
human
howev
case
mmtv
mutat
result
adapt
human
cell
confer
depend
belief
base
follow
evid
first
transient
express
rodent
cho
cell
increas
suscept
mmtvbase
vector
carri
mutant
env
rel
vector
carri
wt
env
second
human
cell
express
downmodul
use
sirna
exhibit
decreas
suscept
mmtvbase
vector
carri
mutant
env
rel
vector
carri
wt
env
third
mmtvbase
vector
carri
mutant
mmtv
env
transduc
knockout
human
cell
effici
similar
cell
express
addit
bind
rate
wt
mutant
mmtv
envprotein
express
cell
histag
protein
immobil
hisab
coat
biosensor
assess
use
blitz
system
fortebio
kinet
characterist
mmtv
env
without
mutat
show
detect
differ
interact
data
shown
eventhough
mutat
rb
adapt
mmtv
use
cell
entri
clearli
shape
receptor
bind
domain
optim
interact
yet
unknown
receptor
evidenc
enhanc
infect
virion
carri
env
interact
could
neutral
specif
antimmtv
serum
support
concept
specif
interact
viral
envelop
cell
surfac
receptor
mediat
entri
human
cell
concept
altern
receptor
support
evid
includ
observ
felin
deriv
suscept
cell
line
crfk
make
cell
suscept
mmtv
infect
thu
felin
cell
must
express
anoth
molecul
differ
enabl
viru
enter
cytoplasm
evid
come
studi
cell
entri
nonpathogen
new
world
arenavirus
typic
use
ortholog
host
speci
receptor
molecul
howev
like
mmtv
report
rel
effici
enter
human
cell
independ
manner
use
far
unidentifi
alterant
receptor
addit
usag
one
cell
surfac
molecul
receptor
rare
report
number
virus
includ
sar
coronavisu
enteroviru
virus
seem
exhibit
even
complex
receptor
depend
involv
engag
multipl
cell
surfac
compon
exampl
hepat
c
viru
hcv
addit
attach
factor
hs
lsign
also
requir
coexpress
four
protein
occludin
entri
cell
review
anoth
variat
use
primari
secondarycoreceptor
cell
entri
prime
exampl
process
sinc
requir
coexpress
coreceptor
addit
primari
receptor
cell
entri
review
final
virus
use
less
specif
interact
attach
factor
bind
cell
surfac
interact
true
receptor
bind
syndecan
enhanc
viru
entri
macrophag
case
mmtv
altern
receptor
may
substitut
function
conjuct
manner
similar
hcv
multipl
cell
surfac
compon
depend
function
downstream
manner
analog
coreceptor
work
identifi
attach
receptor
use
mmtv
enter
human
cell
initi
infect
current
ongo
replic
mmtv
human
cell
led
adapt
viru
new
host
shape
receptor
bind
domain
optim
interact
receptor
data
explain
mechan
enabl
mmtv
form
hostrang
variant
nonmurin
cell
known
long
time
basi
remain
obscur
receptor
mediat
infect
human
cell
remain
identifi
rule
engag
entri
process
identifi
mutat
receptor
bind
site
emerg
result
posit
select
pressur
human
cell
may
serv
marker
mmtv
replic
human
cell
atcc
atcc
nmumg
atcc
atcc
atcc
cell
maintain
dmem
medium
supplement
fetal
bovin
serum
fb
cultur
cell
maintain
humidifi
air
contain
gener
stabl
cell
line
express
green
fluoresc
report
protein
egfp
neomycin
resist
marker
cell
plate
densiti
cell
per
well
sixwel
plate
one
day
transfect
transfect
pcmvegfp
vector
clontech
use
turbofect
transfect
reagent
thermo
scientif
twentyfour
hour
posttransfect
normal
growth
medium
replac
medium
contain
invitrogen
cell
cultur
two
week
express
egfp
cell
analys
uv
microscopi
fcm
knock
cell
use
lenticrispr
vector
system
describ
oligonucleotid
primer
specif
either
figur
b
egfp
design
accord
shalem
et
al
gene
specif
oligo
phosphoryl
end
use
polynucleotid
kinas
pnk
anneal
togeth
give
rise
doubl
strand
insert
carri
cohes
end
compat
bsmbigener
restrict
site
reaction
carri
total
volum
contain
oligo
ligat
buffer
neb
unit
pnk
neb
first
incub
minut
oligo
denatur
min
anneal
togeth
gradual
ramp
temperatur
lenticrispr
vector
digest
bsmbi
neb
remov
spacer
sequenc
ligat
doubl
strand
insert
produc
lentiviru
vector
x
cell
plate
cotransfect
lenticrispr
plasmid
packag
construct
invirogen
rev
express
construct
invitorgen
vsvg
envencod
plasmid
phcmvg
transfect
perform
use
calcium
phosphat
method
thirtysix
hour
posttransfect
viruscontain
supernat
harvest
filter
sarstedt
serial
dilut
undilut
prepar
transduct
target
cell
seed
densiti
x
cell
per
well
plate
one
day
transduct
increas
dilut
filter
viru
supernat
ad
cell
togeth
polybren
replac
fresh
medium
hour
puromycin
ad
cell
hour
post
transduct
cell
transduc
lenticrisprbas
vector
particl
carri
sgrna
target
egfp
maintain
day
analys
uv
microscopi
fcm
cell
transduc
lenticrisprbas
vector
particl
carri
sgrna
target
maintain
day
puromycincontain
medium
singl
clone
expand
genom
dna
extract
analys
endonucleas
assay
follow
dna
sequenc
endonucleas
assay
primer
list
figur
use
gener
bp
pcr
product
encompass
target
site
cycl
condit
consist
min
follow
cycl
final
extens
min
pcr
product
column
purifi
ng
dna
per
sampl
subject
follow
hybridis
reaction
min
ramp
ramp
product
subsequ
digest
unit
endonucleas
neb
reaction
volum
min
mixtur
resolv
agaros
gel
amplicon
carri
nonperfectli
match
dna
digest
endonucleas
clone
plasmid
ta
clone
kit
invitrogen
least
six
clone
analys
sequenc
egfpcontain
mmtv
recombin
virion
carri
one
follow
envelop
protein
mmtv
env
amphotrop
mlv
env
junin
gp
tacarib
gp
prepar
cell
describ
use
transduct
target
cell
briefli
x
cell
plate
cotransfect
packag
construct
mmtv
vector
plasmid
rev
express
construct
construct
express
either
mmtv
env
amphotrop
mlvenv
palf
pathogen
clade
b
arenaviru
gp
junv
nonpathogen
clade
b
arenaviru
gp
tcrv
thirtysix
hour
posttransfect
viruscontain
supernat
harvest
filter
sarstedt
use
transduct
store
target
cell
transduct
seed
densiti
x
cell
per
well
plate
one
day
transduct
vector
contain
supernat
appli
onto
cell
togeth
polybren
replac
fresh
medium
hour
three
day
posttransduct
cell
analys
fcm
filter
sarstedt
cell
cultur
fluid
dexamethason
stimul
dex
sigmaaldrich
cell
produc
infecti
mmtv
particl
x
rna
copi
use
infect
target
cell
seed
concentr
x
cell
per
well
plate
one
day
infect
supernat
ad
cell
togeth
polybren
replac
fresh
medium
hour
singl
round
infect
experi
infect
cell
cultur
one
week
analys
pcr
describ
timecours
experi
infect
cell
cultiv
cell
cultur
medium
either
supplement
dex
week
semiquantit
ltrgagspecif
pcr
qpcr
use
quantifi
provir
dna
load
cours
experi
directli
demonstr
product
infecti
mmtv
particl
persist
infect
cell
mmtv
supernat
infect
cell
cultur
dex
six
week
filter
use
infect
naiv
uninfect
target
cell
ltrgag
pcr
employ
monitor
presenc
provir
sequenc
second
round
infect
cell
infect
experi
normal
viru
titer
x
rna
copi
use
infect
target
cell
seed
plate
infect
neutral
experi
vectorviru
harvest
produc
cell
incub
polyclon
goat
antimmtv
antiserum
kindli
provid
ross
nonspecif
serum
ice
min
infect
heat
inactiv
experi
virusvector
incub
min
prior
infect
azt
treatment
experi
azt
ad
naiv
cell
togeth
viru
inoculum
hour
incub
supernat
replac
fresh
medium
contain
azt
mmtvbase
vector
particl
carri
either
wt
env
mutant
env
incub
indic
amount
heparan
sulfat
sigmaaldrich
h
polybren
ad
mixtur
use
infect
cell
incub
h
cell
refe
fresh
medium
three
day
post
infect
cell
analys
infect
fcm
viru
bind
assay
perform
previous
describ
briefli
mmtv
recombin
virion
carri
either
wt
env
env
gener
describ
vector
particl
concentr
ultracentrifug
rpm
h
rotor
resuspend
phosphatebuff
salin
pb
ph
contain
fb
mm
edta
pbsfe
rel
quantiti
wt
env
g
envcarri
virion
prepar
determin
western
blot
use
antimmtv
ca
antibodi
serial
dilut
viru
stock
singlecel
suspens
nmumg
cell
prepar
incub
cell
pbsfe
min
follow
vigor
pipet
equal
amount
viru
particl
contain
either
wt
env
env
normal
base
western
blot
result
incub
cell
presenc
polybren
h
cell
wash
three
time
resuspend
icecold
pb
contain
fb
sodium
azid
dilut
goat
antimmtv
polyclon
antiserum
ad
incub
addit
min
cell
wash
three
time
incub
fluorescein
isothiocyan
fitc
conjug
rabbit
antigoat
immunoglobulin
antibodi
cell
wash
three
time
analys
fcm
virion
remain
attach
cell
surfac
mmtv
vector
produc
cell
quantifi
follow
subtilisin
treatment
previous
describ
briefli
transfect
cell
cm
dish
produc
recombin
virion
carri
either
wt
env
env
wash
twice
pb
subtilisin
buffer
mm
tri
ph
mm
mm
nacl
treat
mgml
subtilisin
sigmaaldrich
minut
room
temperatur
subtilisin
treatment
stop
ad
dmem
contain
fc
mm
pmsf
mm
egta
virion
releas
subtilisin
treatment
well
virion
constitut
releas
cell
concentr
ultracentrifug
rpm
h
rotor
viru
pellet
resuspend
lysi
buffer
mm
nacl
mm
tri
ph
triton
resuspend
pellet
subject
sdspage
follow
western
blot
analysi
antimmtvca
antibodi
equival
protein
content
whole
cell
lysat
measur
use
dc
protein
assay
biorad
equal
volum
concentr
mmtv
vector
resolv
use
polyacrylamid
gel
transfer
hybondp
membran
ge
healthcar
membran
probe
follow
antibodi
detect
rabbit
antitransferrin
receptor
antibodi
abcam
dilut
detect
betaactin
rabbit
antiactin
antibodi
sigmaaldrich
dilut
detect
mmtv
capsid
protein
rabbit
antimmtvca
antibodi
michael
sakalian
dilut
detect
mmtv
su
tm
subunit
mmtv
env
rabbit
janet
butel
dilut
horseradish
peroxidisekonjug
swine
antirabbit
igg
dako
dilut
secondari
antibodi
use
secondari
antibodi
follow
incub
ecl
prime
western
blot
detect
reagent
kit
ge
healthcar
luminesc
signal
detect
exposur
amersham
ge
healthcar
andor
scan
use
licor
cdigit
blot
scanner
also
allow
quantif
signal
genom
dna
gdna
isol
cell
use
qiagen
dneasi
blood
tissu
kit
qiagen
presenc
mmtv
provir
dna
infect
cell
detect
pcr
use
primer
design
amplifi
bp
long
segment
span
mmtv
ltrgag
region
f
acg
aca
tga
aac
aac
agt
tcc
aat
ggc
tca
ccg
ng
gdna
use
templat
amplif
cycl
condit
consist
initi
denatur
min
follow
cycl
min
final
extens
min
equal
load
pcr
reaction
control
use
gapdhspecif
primer
pair
gapdh
f
gct
cct
gca
cca
cca
gapdh
r
ctg
ctt
cac
cac
ctt
pcr
reaction
cycl
carri
ident
sampl
amount
mmtvspecif
pcr
provir
load
infect
cell
quantifi
realtim
taqman
pcr
use
primer
target
end
mmtv
env
ng
gdna
amplifi
use
follow
set
primer
mmtv
f
aag
tcc
gga
gga
tga
atc
mmtv
cgc
ttc
gga
gat
taa
taqman
probe
caa
aga
gaa
gac
ggc
ttg
gca
aca
taqman
experi
standard
run
consist
serial
dilut
plasmid
carri
molecular
clone
mmtv
cycl
condit
consist
min
follow
cycl
min
threshold
cycl
measur
well
standard
curv
plot
use
threshold
cycl
valu
serial
dilut
plasmid
dna
equal
load
pcr
reaction
verifi
use
taqman
realtim
pcr
specif
human
apob
gene
use
follow
primer
taqman
probe
hapob
f
tta
cca
cac
atc
tct
tga
ttc
tct
hapob
r
ctt
cac
tgg
aca
agg
tca
tac
taqman
probe
tcg
tcc
agg
tgc
gaa
gca
gac
ident
pcr
condit
outlin
employ
gdna
isol
cell
two
week
infect
mmtv
viru
harvest
persist
infect
cell
viral
rna
extract
supernat
cell
tri
reagent
sigmaaldrich
use
extract
cdna
synthesi
rna
treat
dnase
turbo
dnafre
kit
ambion
revers
transcrib
use
primer
gca
ctc
ttt
tat
atc
ttg
superscript
ii
revers
transcriptas
invitrogen
gdna
cdna
subsequ
use
longtempl
pcr
expand
long
templat
pcr
system
roch
use
primer
ggt
acc
ggc
tca
gaa
ggc
ttc
gga
aga
atg
cgg
ccg
cgg
ctc
aga
agg
ctt
cgg
carri
noti
restrict
site
ital
respect
result
pcr
fragment
clone
correspond
site
vector
invitrogen
sequenc
use
overlap
primer
avail
author
upon
request
cell
plate
densiti
cell
per
well
sixwel
plate
one
day
transfect
transfect
overnight
human
tfrc
smartpool
nm
dharmacon
nontarget
pool
dharmacon
sirna
use
dharmafect
thermo
scientif
fortyeight
hour
posttransfect
cell
either
infect
wildtyp
mmtv
viru
transduc
egfpcontain
mmtvbase
vector
particl
carri
wt
mutant
mmtv
env
infect
target
cell
mmtv
viru
assess
ltrgag
pcr
one
week
infect
transduct
target
cell
egfpcarri
mmtv
vector
assess
fcm
hour
posttransduct
cho
cell
plate
densiti
cell
per
well
sixwel
plate
one
day
transfect
transfect
express
vector
kindli
donat
ross
express
vector
kindli
donat
p
cannon
parent
vector
use
turbofect
transfect
reagent
thermo
scientif
fortyeight
hour
posttransfect
cell
either
infect
wildtyp
mmtv
viru
transduc
egfpcontain
mmtvbase
vector
particl
carri
wt
mutant
env
infectiontransduct
assess
describ
